Jaguar Health Inc
For the period ended Mar 31, 2024. Filed May 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 14, 2024
JAGX$0.44+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Losses
| | | | | | |
|---|---|---|---|---|---|
| | Three Months Ended | ||||
| | March 31, | ||||
| (In thousands, except share and per share data) · 2024 · 2023 | |||||
| Net loss | $(9,368) | | $(12,397) | ||
| Other comprehensive gains (loss) | | 217 | | | (232) |
| Net comprehensive loss | $(9,151) | | $(12,629) | ||
| Common stockholders: | | | | | |
| Net loss attributable to common stockholders | $(9,226) | | $(12,202) | ||
| Other comprehensive loss attributable to common stockholders | | | | | |
| Translation adjustments | | 191 | | | (204) |
| Net comprehensive loss attributable to common stockholders | $(9,035) | | $(12,406) | ||
| Non-controlling interests: | | | | | |
| Net loss attributable to non-controlling interests | $(142) | | $(195) | ||
| Other comprehensive loss attributable to non-controlling interests | | | | | |
| Translation adjustments | | 26 | | | (28) |
| Net comprehensive loss attributable to non-controlling interests | $(116) | | $(223) | ||
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.